Parnassus Investments' "Parnassus Value Equity Fund" outperformed the Russell 1000 Value Index in Q1 2024. Key contributors were stock selections in IT and Communication sectors. BioMarin Pharmaceutical Inc. was highlighted as a top holding with potential for growth.